Evaluation of the Association Between the Effects of Generalized Stage 3 and 4 Periodontitis on Arterial Stiffness and Cardiovascular Risk: the PAROCAR Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-69
SponsorNantes University Hospital

About this trial

Periodontal diseases are chronic inflammatory conditions affecting nearly half of the adult population and are associated with systemic inflammatory responses. Recent evidence suggests a possible link between severe periodontitis and cardiovascular diseases through shared inflammatory pathways.

The PAROCAR study aims to evaluate the association between generalized periodontitis (stages 3 and 4, 2017 Chicago Classification) and arterial stiffness measured by pulse wave velocity (PWV), compared to matched controls without periodontitis, adjusted for conventional cardiovascular risk factors.

Eligibility criteria

Qualifiers

Age 40-69 years

Minimum of 12 teeth (3 per quadrant)

Written informed consent Exposed group: generalized periodontitis stage 3 or 4 (Chicago 2017 Classification) Non-exposed group: healthy periodontium

Disqualifiers

Patients diagnosed with diabetes,

Patients diagnosed with hypertension or with a history of severe cardiovascular disease,

Patients diagnosed with familial hypercholesterolaemia,

Patients with a medical history or current condition that, in the investigator's opinion, is likely to interfere with the study results,

Trial design

Treatments tested in this trial

  • Periodontal examination and pulse wave velocity

Treatment groups

206 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Nantes University Hospital

Lead sponsor

French Interregional Group of Clinical Research and Innovation

Collaborator

Université de Nantes

Collaborator

Axelife company

Collaborator